You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GEJ

Showing 1 - 25 of 318
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer Trial in Tianjin (AK104, Apatinib, Paclitaxel)

Recruiting
  • Gastric Cancer
  • Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
May 7, 2023

Gastric Cancer, Gastroesophageal Junction (GEJ) Cancer Trial (T-Dxd(Trastuzmab deruxtecan), Ramucirumab)

Not yet recruiting
  • Gastric Cancer
  • Gastroesophageal Junction (GEJ) Cancer
  • T-Dxd(Trastuzmab deruxtecan), Ramucirumab
  • (no location specified)
Jun 7, 2023

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Tucson (Tadalafil 20 MG)

Not yet recruiting
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Tadalafil 20 MG
  • Tucson, Arizona
    Arizona Cancer Center at UMC North/University Medical Center
Feb 1, 2023

Esophageal Cancer, Esophageal Tumors Trial in Milano (hybrid PET/MRI)

Recruiting
  • Esophageal Cancer
  • Esophageal Neoplasms
  • hybrid PET/MRI
  • Milano, Italy
    Deaprtment of Radiology, IRCCS Ospedale San Raffaele
Jan 24, 2023

Gastric Cancer, Gastroesophageal-junction Cancer, Advanced Cancer Trial (TST001, CapOx or mFOLFOX6 and NIVO or (Substudy)

Not yet recruiting
  • Gastric Cancer
  • +2 more
  • TST001, CapOx or mFOLFOX6 and NIVO or (Substudy) TST001, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)
  • Placebo CapOx or mFOLFOX6 and NIVO or (Substudy) Placebo, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)
  • (no location specified)
Oct 16, 2023

Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer, Locally Advanced Unresectable Gastric

Available
  • Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer
  • +3 more
  • Morristown, New Jersey
    AMG Hematology/Oncology
Sep 15, 2023

Gastric Cancer, Gastroesophageal-junction Cancer, Esophageal Cancer Trial (LB1908)

Not yet recruiting
  • Gastric Cancer
  • +3 more
  • LB1908
  • (no location specified)
Sep 9, 2022

Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma Trial in Guangzhou (zolbetuximab)

Completed
  • Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma
  • Guangzhou, China
    Site CN86001
Jan 11, 2022

Gastric or Gastroesophageal Junction Adenocarcinoma Trial in Nanjing (neoadjuvant chemo-hypofractionated radiotherapy plus PD-1

Active, not recruiting
  • Gastric or Gastroesophageal Junction Adenocarcinoma
  • neoadjuvant chemo-hypofractionated radiotherapy plus PD-1 antibody (Tislelizumab)
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Hospital
Jul 4, 2023

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Houston (Fluorouracil, Leucovorin, Oxaliplatin)

Not yet recruiting
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Houston, Texas
  • +3 more
Nov 13, 2022

PD-L1 Positive Locally Advanced Patients With Resectable Gastric Cancer Trial in Changchun (Drug: Toripalimab,

Recruiting
  • PD-L1 Positive Locally Advanced Patients With Resectable Gastric Cancer
  • Drug: Toripalimab, FLOT(Docetaxel+oxaliplatin+leucovorin+5-FU)
  • Changchun, Ji Lin, China
    First Hospital of Jilin University
Jul 18, 2022

HER2-positive Gastric Cancer Trial in United States (Cinrebafusp alfa (PRS-343) in combination with ramucirumab and paclitaxel,

Recruiting
  • HER2-positive Gastric Cancer
  • Cinrebafusp alfa (PRS-343) in combination with ramucirumab and paclitaxel
  • Cinrebafusp alfa (PRS-343) in combination with tucatinib
  • Santa Barbara, California
  • +3 more
Jan 14, 2022

Adenocarcinoma - GEJ, Gastric Adenocarcinoma Trial (Dostarlimab)

Not yet recruiting
  • Adenocarcinoma - GEJ
  • Gastric Adenocarcinoma
  • (no location specified)
Sep 26, 2023

Adenocarcinoma - GEJ, Adenocarcinoma of the Stomach Trial in Bengbu (HER2 Tumor Vaccine, HER2 Tumor Vaccine+ Standard of Care

Recruiting
  • Adenocarcinoma - GEJ
  • Adenocarcinoma of the Stomach
  • HER2 Tumor Vaccine
  • HER2 Tumor Vaccine+ Standard of Care chemotherapy
  • Bengbu, Anhui, China
    First Affiliated Hospital Bengbu Medical College
Apr 6, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Japan (ASP2138)

Recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • Santa Monica, California
  • +5 more
Dec 13, 2022

Stomach Tumors, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Atezolizumab, Tiragolumab, Oxaliplatin)

Active, not recruiting
  • Stomach Neoplasms
  • +2 more
  • Beijing, China
  • +10 more
Dec 21, 2022

Gastric Cancer, Peritoneal Metastases, Ascites, Malignant Trial in Hangzhou (Sintilimab in Combination With S-1/oxaliplatin With

Recruiting
  • Gastric Cancer
  • +2 more
  • Sintilimab in Combination With S-1/oxaliplatin With nab-paclitaxel intraperitoneal infusion
  • Blood samples, tumor biopsy specimens, ascites, and feces samples will be collected
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Sep 18, 2023

Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma Trial in China (Trastuzumab Deruxtecan)

Recruiting
  • Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
  • Trastuzumab Deruxtecan
  • Beijing, China
  • +25 more
Jul 27, 2022

Gastric Cancer Trial in Zhengzhou (Fruquintinib + RC48)

Not yet recruiting
  • Gastric Cancer
  • Fruquintinib + RC48
  • Zhengzhou, Henan, China
    The First Affiliated Hospital of Zhengzhou University
Feb 6, 2022

HER2-positive Advanced Gastric Cancer, HER2-positive Gastroesophageal Junction Adenocarcinoma Trial (Trastuzumab deruxtecan)

Not yet recruiting
  • HER2-positive Advanced Gastric Cancer
  • HER2-positive Gastroesophageal Junction Adenocarcinoma
  • Trastuzumab deruxtecan
  • (no location specified)
Aug 11, 2023

Gastric Cancer, Gastroesophageal-junction Cancer Trial in Wuhan, Nanjing, Taiyuan (Tislelizumab, S-1, Oxaliplatin)

Not yet recruiting
  • Gastric Cancer
  • Gastroesophageal-junction Cancer
  • Wuhan, Hubei, China
  • +2 more
Jan 16, 2023

Metastatic HER2 Positive Gastroesophageal Junction Cancer Trial in La Jolla, Washington, Hackensack (CYNK-101, Pembrolizumab,

Recruiting
  • Metastatic HER2 Positive Gastroesophageal Junction Cancer
  • CYNK-101
  • +6 more
  • La Jolla, California
  • +2 more
Jul 12, 2022

Gastric Cancer, GastroEsophageal Cancer Trial in Aurora, Colorado Springs, Highlands Ranch (Pembrolizumab, Olaparib,

Recruiting
  • Gastric Cancer
  • GastroEsophageal Cancer
  • Aurora, Colorado
  • +2 more
Jan 4, 2023

Gastroesophageal Junction (GEJ) Adenocarcinoma Trial in Beijing (Q-1802 Injection,Oxaliplatin Injection,Capecitabine)

Recruiting
  • Gastroesophageal Junction (GEJ) Adenocarcinoma
  • Q-1802 Injection,Oxaliplatin Injection,Capecitabine
  • Beijing, Beijing, China
    Beijing cancer hospical
Jul 27, 2023

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Beijing (CS1001 mAb, CS1001 , Oxaliplatin)

Active, not recruiting
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • CS1001 monoclonal antibody
  • +3 more
  • Beijing, China
    Beijing Cancer Hospital
Sep 27, 2022